|
Patheon to Host Q3 2007 Financial Results Conference Call and Webcast
TORONTO, Canada (August 22, 2007) – Patheon Inc. (TSX: PTI) today announced that it will host a conference call with financial analysts on Friday, September 7, 2007 at 10:00 a.m. (EDT) to discuss its third quarter 2007 financial results. The third quarter financial results news release will be issued at approximately 7:00 a.m. (EDT) on Friday, September 7, 2007.
Representing Patheon on the call will be: Riccardo Trecroce, Chief Executive Officer; Nick DiPietro, President and Chief Operating Officer; and John Bell, Chief Financial Officer. The call will begin with a brief presentation, followed by a question-and-answer period with investment analysts.
Interested parties are invited to access the live call, via telephone, in listen-only mode, at (416) 644-3414 (Toronto and International) or toll free at (800) 733-7571 (U.S., including Puerto Rico). Listeners are encouraged to dial in five to 15 minutes in advance to avoid delays. A live audio webcast, with a slide presentation, will also be available via the web at www.patheon.com. (Please note that Windows Media Player or RealPlayer is required.)
A telephone replay of the conference call will be available between Friday, September 7, 2007 and Friday, September 21, 2007 by calling (416) 640-1917 or (877) 289-8525 (toll free) and entering identification number 21244632, followed by the “#” key. The webcast will also be archived on www.patheon.com for three months.
Contacts: Mr. Riccardo Trecroce, Chief Executive Officer, Tel: (905) 812-6877, Fax: (905) 812-6613, Email: rtrecroce@patheon.com; Mr. John Bell, Chief Financial Officer, Tel: (905) 812-6812, Fax: (905) 812-6613, Email: john.h.bell@patheon.com; Ms. Shelley Jourard, Director, Corporate Communications, Tel: (905) 812-6614, Fax: (905) 812-6613; Email: sjourard@patheon.com
Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug development and manufacturing services to the international pharmaceutical industry. Patheon operates a network of 14 facilities in the United States, Canada and Europe, employing more than 5,300 people and serving a client base of more than 250 pharmaceutical and biotechnology companies.
-30- |